Faecal microbiota transplantation: Key points to consider

Annales pharmaceutiques françaises
P Bourlioux, workgroup of the French Academy of Pharmacy

Abstract

Faecal microbiota transplantation (FMT) from a healthy donor has become the gold standard treatment for patients suffering from recurrent Clostridium difficile infection where antibiotic treatment (with vancomycin, metronidazole or fidaxomicin) has failed. FMT eradicates C. difficile and helps restore the recipient's intestinal flora, but its mechanism of action remains unclear. Since FMT's complex and highly variable composition cannot be easily characterized - nor its quality routinely assessed - FMT as a sui generis biologic drug cannot conform to existing standards for preparation. Clearly, donors must be carefully selected and the raw material prepared under close microbiological control, but FMT should also conform to manufacturing and laboratory practice standards for which international consensus can only be achieved with further experience. The objective should be to engage biomedical research to develop protocols that help elucidate the mechanism of action of FMT and support the production of safe and efficacious products.

References

Apr 3, 2008·Mayo Clinic Proceedings·John K DiBaiseBruce E Rittmann
Oct 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Harry SokolPhilippe Langella
Mar 6, 2010·Science·Matam Vijay-KumarAndrew T Gewirtz
Sep 29, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Alan W Walker, Trevor D Lawley
Jan 18, 2013·The New England Journal of Medicine·Els van NoodJosbert J Keller
Jan 22, 2013·PloS One·Amber N McCoyTemitope O Keku
Feb 12, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Qingchao ZhuHuanlong Qin
Feb 20, 2013·The Journal of Infectious Diseases·Glen D ArmstrongPaul L Beck
Mar 12, 2013·Gastroenterology·Kirsten TillischEmeran A Mayer
Apr 27, 2013·Nature Reviews. Immunology·Nobuhiko KamadaGabriel Núñez
May 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Amandine EverardPatrice D Cani
Jun 14, 2013·Biological Psychiatry·Timothy G DinanJohn F Cryan
Jun 19, 2013·Journal of Bacteriology·Melissa J MartinBrendan W Wren
Aug 31, 2013·Science·Jop de Vrieze
Oct 15, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S B DebastUNKNOWN European Society of Clinical Microbiology and Infectious Diseases
Jan 21, 2014·Annales pharmaceutiques françaises·P Bourlioux
Jan 30, 2014·PloS One·Katherine R HargreavesMartha R J Clokie
Jul 7, 2014·Annales pharmaceutiques françaises·F MegerlinP Bourlioux
Aug 12, 2014·Cancer Prevention Research·Joseph P ZackularPatrick D Schloss
Sep 16, 2014·Annales pharmaceutiques françaises·P BourliouxM-J Butel
Sep 16, 2014·Annales pharmaceutiques françaises·F Megerlin, E Fouassier
Oct 17, 2014·JAMA : the Journal of the American Medical Association·Ilan YoungsterElizabeth L Hohmann

❮ Previous
Next ❯

Citations

Jan 24, 2018·World Journal of Gastroenterology : WJG·Sheng-Xuan LiuSai-Nan Shu
Sep 2, 2017·European Journal of Gastroenterology & Hepatology·Simon M D JørgensenChristian L Hvas
Feb 9, 2021·Frontiers in Medicine·Elisavet StavropoulouEugenia Bezirtzoglou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
R J Porter
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive
Giuseppe RusselloEdoardo Carretto
Annales pharmaceutiques françaises
F Megerlin, E Fouassier
Clinical Cancer Investigation Journal
Szabolcs VigváriZoltán Péterfi
The New England Journal of Medicine
Nasia Safdar, William A Craig
© 2022 Meta ULC. All rights reserved